Compound: FDB023465 (Lactosylceramide (d18:1/12:0))
Term: Abetalipoproteinemia
Definition: A hypolipoproteinemia that is characterized by an inablility to fully absorb dietary fats, cholesterol and fat-soluble vitamins, has physical basis in an autosomal recessive disorder of lipid metabolism that has material basis in mutation in the microsomal triglyceride transfer protein that catalyzes the transport of lipids (triglycerides; cholesterol esters; phospholipids) and is required in the secretion of beta-lipoproteins (low density lipoproteins or ldl). (do).
Parent Term: Health condition
Parent Definition: A health effect that consists on short or long-term disease, condition, disorder, syndrome or constant abnormality.
Synonyms
Other Compounds Mapped to 'Abetalipoproteinemia'